The Consumer Product Safety Commission has issued two related notices on certain infant cushions/pillows as follows:
In June 2008, the U.S. Census Bureau issued its final rule to amend the Foreign Trade Statistics Regulations (15 CFR Part 30) to make mandatory the filing of export information through the Automated Export System or AESDirect, for all shipments where a Shipper's Export Declaration (SED) is currently required, etc.
U.S. Customs and Border Protection has posted an Excel spreadsheet listing the reject reasons for July 2008 for CBP Form 5106 Importer ID input records, CBP Form 301 Customs bonds, bond riders, bond terminations, etc.
The Food and Drug Administration is holding a public meeting on September 8, 2008 and is requesting public comments by October 24, 2008 on the implementation of recommendations made by the Nanotechnology Task Force Report (the Report) relating to the development of FDA guidances.
U.S. Customs and Border Protection has issued a CSMS message regarding the transmission of the grower as the Food and Drug Administration manufacturer.
On July 31, 2008, the Senate passed the Consumer Product Safety Improvement Act of 2008 (H.R. 4040) conference report, clearing it for the President. (See ITT's Online Archives or 07/31/08 news, 08073110, for BP summary of the H.R. 4040 conference report.) (Congressional Record, dated 07/31/08 news, available at http://thomas.loc.gov/cgi-bin/query/B?r110:@FIELD(FLD003d)@FIELD(DDATE20080731))
The Office of the U.S. Trade Representative has issued a notice requesting written comments on its Special 301 out-of-cycle review (OCR) of Taiwan regarding its intellectual property protection and enforcement.
On July 17, 2008, House Ways and Means Committee Chairman Rangel and Trade Subcommittee Chairman Levin introduced H.R. 6530, the Trade Enforcement Act of 2008, to amend U.S. trade laws to eliminate foreign barriers to exports of U.S. goods and services, restore rights under trade remedy laws, strengthen enforcement of U.S. intellectual property rights (IPR) and health and safety laws at U.S. borders, and for other purposes.
U.S. Customs and Border Protection has posted an Excel spreadsheet listing the reject reasons for June 2008 for CBP Form 5106 Importer ID input records, CBP Form 301 Customs bonds, bond riders, bond terminations, etc.
As part of its ongoing review of over-the-counter (OTC) drug products, the Food and Drug Administration has issued a proposed rule to add to 21 CFR 310.545 drug products containing certain active ingredients offered OTC for certain uses as not generally recognized as safe and effective (GRASE).